These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8960858)
1. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858 [TBL] [Abstract][Full Text] [Related]
2. SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties. Matsuno K; Senda T; Kobayashi T; Okamoto K; Nakata K; Mita S Behav Brain Res; 1997 Feb; 83(1-2):221-4. PubMed ID: 9062689 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181 [TBL] [Abstract][Full Text] [Related]
4. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats. Senda T; Matsuno K; Kobayashi T; Nakazawa M; Nakata K; Mita S Pharmacol Biochem Behav; 1998 Jan; 59(1):129-34. PubMed ID: 9443547 [TBL] [Abstract][Full Text] [Related]
5. Reduction of the scopolamine-induced impairment of passive-avoidance performance by sigma receptor agonist in mice. Senda T; Matsuno K; Kobayashi T; Mita S Physiol Behav; 1997 Feb; 61(2):257-64. PubMed ID: 9035256 [TBL] [Abstract][Full Text] [Related]
6. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Zou LB; Yamada K; Sasa M; Nakata Y; Nabeshima T Neuropharmacology; 2000 Jul; 39(9):1617-27. PubMed ID: 10854906 [TBL] [Abstract][Full Text] [Related]
7. Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. Zou LB; Yamada K; Nabeshima T Eur J Pharmacol; 1998 Aug; 355(1):1-10. PubMed ID: 9754932 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice. Hiramatsu M; Mizuno N; Kanematsu K Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533 [TBL] [Abstract][Full Text] [Related]
9. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors. Hiramatsu M; Hoshino T Brain Res; 2005 Sep; 1057(1-2):72-80. PubMed ID: 16125682 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain. Kobayashi T; Matsuno K; Nakata K; Mita S J Pharmacol Exp Ther; 1996 Oct; 279(1):106-13. PubMed ID: 8858982 [TBL] [Abstract][Full Text] [Related]
11. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist. Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641 [TBL] [Abstract][Full Text] [Related]
12. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors. Noda A; Noda Y; Kamei H; Ichihara K; Mamiya T; Nagai T; Sugiura S; Furukawa H; Nabeshima T Neuropsychopharmacology; 2001 Apr; 24(4):451-60. PubMed ID: 11182540 [TBL] [Abstract][Full Text] [Related]
13. SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Maurice T; Privat A Eur J Pharmacol; 1997 Jun; 328(1):9-18. PubMed ID: 9203561 [TBL] [Abstract][Full Text] [Related]
14. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Nakazawa M; Matsuno K; Mita S Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556 [TBL] [Abstract][Full Text] [Related]
15. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Matsuno K; Kobayashi T; Tanaka MK; Mita S Eur J Pharmacol; 1996 Oct; 312(3):267-71. PubMed ID: 8894608 [TBL] [Abstract][Full Text] [Related]
16. Involvement of kappa-opioid and sigma receptors in short-term memory in mice. Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064 [TBL] [Abstract][Full Text] [Related]
17. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Maurice T; Su TP; Privat A Neuroscience; 1998 Mar; 83(2):413-28. PubMed ID: 9460750 [TBL] [Abstract][Full Text] [Related]
18. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Kobayashi T; Matsuno K; Murai M; Mita S Neurochem Res; 1997 Sep; 22(9):1105-9. PubMed ID: 9251100 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. Kawamura K; Elsinga PH; Kobayashi T; Ishii S; Wang WF; Matsuno K; Vaalburg W; Ishiwata K Nucl Med Biol; 2003 Apr; 30(3):273-84. PubMed ID: 12745019 [TBL] [Abstract][Full Text] [Related]
20. Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Matsuno K; Senda T; Matsunaga K; Mita S Eur J Pharmacol; 1994 Aug; 261(1-2):43-51. PubMed ID: 8001652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]